Title: Update to the Diagnostic Serology Journey of SARS-CoV-2
Date: Wednesday, June 10, 2020
Time: 02:00 PM Singapore Time
Duration: 30 minutes
In this webinar, Gavin A. Cloherty, head of Infectious Disease Research for Abbott’s diagnostics business will review how antibody testing enables us to move from “clinical treatment” to epidemiological strategy / population assessment and management. He will also discuss strategies to identify the scope of the pandemic and not just individual infections.
Research Fellow, Volwiler Society Head of Infectious Disease Research
Gavin A. Cloherty graduated from the National University of Ireland, Galway, where he received his Ph.D. in molecular biology and a Bachelor of Science in microbiology and zoology. Gavin has more than 20 years of experience with Abbott and leads a team of scientists in the study ofthe viral diversity of HIV and hepatitis. He provides scientific leadership in the area of infectious disease diagnostics by conducting groundbreaking clinical studies and his innovative research is changing the way infectious diseases are being diagnosed to help improve patient outcomes.